IonQ to Participate in Quantum Korea 2025 and Support Quantum Hackathon for Emerging Talent
COLLEGE PARK, Md., June 23, 2025--(BUSINESS WIRE)--IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced its participation in Quantum Korea 2025, taking place June 24–26 at the aT Center in Seoul. As part of its ongoing commitment to quantum education and ecosystem development, IonQ will also collaborate with Sungkyunkwan University to support a quantum hackathon aimed at fostering the next generation of quantum talent in South Korea.
IonQ Chief Marketing Officer Margaret Arakawa and Chief Revenue Officer Rima Alameddine are scheduled to present the company's updated technology and business roadmap following the recent acquisitions of Oxford Ionics and Lightsynq, and a majority stake in ID Quantique (IDQ). The exhibit floor presentation entitled "Exploring Quantum" is scheduled for Thursday, June 26, 2025 at 2:15 pm local time. IonQ will also demonstrate the IDQ Solteris Network Appliance, part of IDQ's Quantum Safe Ecosystem, designed to upgrade network infrastructure with quantum-safe encryption.
This year marks IonQ's third consecutive sponsorship of Quantum Korea, a leading conference organized by South Korea's Ministry of Science and ICT that explores global trends in quantum innovations. IonQ executives will participate in key sessions, presenting updates on the company's technology roadmap and highlighting collaborations with South Korean partners.
"Global partnerships have been fundamental to IonQ's growth, and our collaborations in South Korea are among the most impactful," said Niccolo de Masi, CEO of IonQ. "We're proud to contribute to the vibrant quantum ecosystem in South Korea and to support initiatives that cultivate the next generation of quantum innovators."
IonQ's sponsorship of Quantum Korea continues its ongoing support of South Korea's quantum initiatives. The company has contributed to Korea's National Quantum Strategy and supported multiple quantum hackathons and academic initiatives. Most recently, IonQ signed agreements with Seoul National University and Sungkyunkwan University to support quantum research and workforce development. IonQ also signed a memorandum of understanding (MoU) with Busan Metropolitan City, Intellian, and the Korea Institute of Science and Technology Information (KISTI), with the intent to integrate IonQ's quantum technology into South Korea's high-performance computing infrastructure and support talent development initiatives. IonQ also announced plans to enter into a global quantum strategic partnership with SK Telecom, South Korea's largest wireless telecommunications operator.
Conference attendees can meet IonQ representatives at Booth #B-07 where they can learn more about the company's roadmap, and its latest quantum networking innovations.
About IonQ
IonQ, Inc. is a leading commercial quantum computing and networking company, delivering high-performance systems aimed at solving the world's largest and most complex commercial and research use cases. IonQ's current generation quantum computers, IonQ Forte and IonQ Forte Enterprise, are the latest in a line of cutting-edge systems and represent the forefront of the company's technological roadmap as it advances toward its goal of building quantum computers with 2 million physical qubits by 2030. The company's innovative technology and rapid growth were recognized in Newsweek's 2025 Excellence Index 1000, Forbes' 2025 Most Successful Mid-Cap Companies list, and Built In's 2025 100 Best Midsize Places to Work in Washington DC and Seattle, respectively. Available through all major cloud providers, IonQ is making quantum computing more accessible and impactful than ever before. Learn more at IonQ.com.
IonQ Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words "advances," "aimed," "available," "commitment," "contribute," "cutting-edge," "delivering," "forefront," "goal," "growth," "intent," "latest," "leading" "ongoing," "plans," "solving," "strategic," "support," "will," and other similar expressions are intended to identify forward-looking statements. These statements include those related to the IonQ's quantum computing capabilities and plans; IonQ's technology driving commercial quantum advantage or delivering scalable, fault-tolerant quantum computing in the future; the necessity, effectiveness, and future impacts of IonQ's offerings available today; and the scalability, fidelity, efficiency, accessibility, effectiveness, importance, reliability, performance, speed, impact, practicality, feasibility, and commercial-readiness of IonQ's offerings. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: IonQ's ability to implement its technical roadmap; changes in the competitive industries in which IonQ operates, including development of competing technologies; IonQ's ability to deliver, and customers' ability to generate, value from IonQ's offerings; IonQ's ability to sell effectively to government entities and large enterprises; IonQ's ability to implement its business plans, forecasts, roadmaps and other expectations, to identify and realize partnerships and opportunities, and to engage new and existing customers; IonQ's ability to effectively enter new markets; IonQ's ability to deliver services and products within currently anticipated timelines; IonQ's inability to effectively integrate its acquisitions of Qubitekk, Inc. and Lightsynq Technologies, Inc. assets and its acquisition of a majority interest in ID Quantique, SA; IonQ's customers deciding or declining to extend contracts into new phases; changes in government spending or policy that may affect IonQ's customers; and risks associated with government sales, including availability of funding and provisions that may allow the government to unilaterally terminate or modify contracts for convenience. You should carefully consider the foregoing factors and the other risks and uncertainties disclosed in the Company's filings, including but not limited to those described in the "Risk Factors" section of IonQ's filings with the U.S. Securities and Exchange Commission, including but not limited to the Company's most recent Annual Report on Form 10-K and reports on Form 10-Q. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and IonQ assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. IonQ does not give any assurance that it will achieve its expectations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250623062556/en/
Contacts
IonQ Media contact: Jane Mazurpress@ionq.co
IonQ Investor Contact: investors@ionq.co
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
MakeMyTrip Limited (MMYT): A Bull Case Theory
We came across a bullish thesis on MakeMyTrip Limited on Stock Analysis Compilation's Substack. In this article, we will summarize the bulls' thesis on MMYT. MakeMyTrip Limited's share was trading at $101.62 as of July 24th. MMYT's trailing P/E were 118.49 according to Yahoo Finance. MakeMyTrip is India's leading online travel agency (OTA), often seen as the of India, leveraging an asset-light, cash-generative internet platform that connects over 80 million customers with hotels, alternative accommodations, and transport options, including flights, trains, buses, and cars. Operating in a young but rapidly growing market, the company benefits from strong brand equity and entrenched scale advantages, underpinned by its extensive network. India's travel sector is set to expand significantly, driven by rising disposable incomes, a growing middle class, and accelerating smartphone penetration, all of which position MakeMyTrip for sustained top-line growth. The company is targeting approximately 20% annual revenue growth, supported by continuous improvements to its network and technology infrastructure. This growth, combined with operational efficiencies, is expected to drive steady margin expansion and position the company to deliver earnings growth in the range of 25%. MakeMyTrip's model remains highly cash-generative, enabling reinvestment into its platform while maintaining a disciplined capital structure. With its dominant market position, brand strength, and scalable business model, the company stands to consolidate its leadership in India's online travel ecosystem. The structural tailwinds of increasing digital adoption and consumer demand for flexible, convenient travel solutions reinforce the long-term investment case. Given its robust fundamentals, attractive growth trajectory, and margin expansion potential, MakeMyTrip offers investors an opportunity to participate in the sustained digital transformation of India's travel industry, with significant upside supported by both network effects and favorable secular trends. Previously, we covered a bullish thesis on Group Limited (TCOM) by Acid Investments in February 2025, which highlighted its reinvestment strategy, strong international growth, and leverage to the global travel rebound. The company's stock price has appreciated by approximately 12.83% since our coverage, as demand remained resilient. Stock Analysis Compilation shares a similar view but emphasizes MakeMyTrip's leadership in India's expanding online travel market supported by network effects. MakeMyTrip Limited is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 26 hedge fund portfolios held MMYT at the end of the first quarter which was 28 in the previous quarter. While we acknowledge the potential of MMYT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Those who invested in Multi-Chem (SGX:AWZ) five years ago are up 457%
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But on a lighter note, a good company can see its share price rise well over 100%. Long term Multi-Chem Limited (SGX:AWZ) shareholders would be well aware of this, since the stock is up 276% in five years. It's down 2.1% in the last seven days. Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During five years of share price growth, Multi-Chem achieved compound earnings per share (EPS) growth of 32% per year. This EPS growth is remarkably close to the 30% average annual increase in the share price. That suggests that the market sentiment around the company hasn't changed much over that time. Rather, the share price has approximately tracked EPS growth. The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image). We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. This free interactive report on Multi-Chem's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. What About Dividends? When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Multi-Chem, it has a TSR of 457% for the last 5 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments! A Different Perspective Multi-Chem's TSR for the year was broadly in line with the market average, at 29%. It has to be noted that the recent return falls short of the 41% shareholders have gained each year, over half a decade. Although the share price growth has slowed, the longer term story points to a business well worth watching. It's always interesting to track share price performance over the longer term. But to understand Multi-Chem better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 1 warning sign for Multi-Chem you should know about. Multi-Chem is not the only stock insiders are buying. So take a peek at this free list of small cap companies at attractive valuations which insiders have been buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Singaporean exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Is There An Opportunity With China Aviation Oil (Singapore) Corporation Ltd's (SGX:G92) 48% Undervaluation?
Key Insights The projected fair value for China Aviation Oil (Singapore) is S$2.26 based on 2 Stage Free Cash Flow to Equity China Aviation Oil (Singapore) is estimated to be 48% undervalued based on current share price of S$1.18 Industry average discount to fair value of 65% suggests China Aviation Oil (Singapore)'s peers are currently trading at a higher discount How far off is China Aviation Oil (Singapore) Corporation Ltd (SGX:G92) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by projecting its future cash flows and then discounting them to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex. We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The Method We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 Levered FCF ($, Millions) US$68.2m US$72.8m US$66.6m US$63.1m US$61.2m US$60.3m US$60.2m US$60.5m US$61.1m US$62.0m Growth Rate Estimate Source Analyst x1 Analyst x1 Est @ -8.55% Est @ -5.27% Est @ -2.98% Est @ -1.38% Est @ -0.26% Est @ 0.53% Est @ 1.08% Est @ 1.46% Present Value ($, Millions) Discounted @ 5.8% US$64.5 US$65.0 US$56.2 US$50.3 US$46.1 US$43.0 US$40.5 US$38.5 US$36.7 US$35.2 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = US$476m We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.4%. We discount the terminal cash flows to today's value at a cost of equity of 5.8%. Terminal Value (TV)= FCF2035 × (1 + g) ÷ (r – g) = US$62m× (1 + 2.4%) ÷ (5.8%– 2.4%) = US$1.8b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$1.8b÷ ( 1 + 5.8%)10= US$1.0b The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is US$1.5b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of S$1.2, the company appears quite good value at a 48% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. Important Assumptions We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at China Aviation Oil (Singapore) as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 5.8%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Check out our latest analysis for China Aviation Oil (Singapore) SWOT Analysis for China Aviation Oil (Singapore) Strength Earnings growth over the past year exceeded the industry. Currently debt free. Dividends are covered by earnings and cash flows. Weakness Dividend is low compared to the top 25% of dividend payers in the Oil and Gas market. Opportunity Annual revenue is forecast to grow faster than the Singaporean market. Trading below our estimate of fair value by more than 20%. Threat No apparent threats visible for G92. Looking Ahead: Although the valuation of a company is important, it ideally won't be the sole piece of analysis you scrutinize for a company. The DCF model is not a perfect stock valuation tool. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. Why is the intrinsic value higher than the current share price? For China Aviation Oil (Singapore), we've compiled three relevant factors you should consider: Risks: For instance, we've identified 1 warning sign for China Aviation Oil (Singapore) that you should be aware of. Future Earnings: How does G92's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing! PS. Simply Wall St updates its DCF calculation for every Singaporean stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
